Page last updated: 2024-08-24

rubitecan and Acquired Immune Deficiency Syndrome

rubitecan has been researched along with Acquired Immune Deficiency Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brady, JN; Doniger, J; Hung, CL; Palini, A; Pantazis, P; Radonovich, MF; Sadaie, MR; Snyder, SW	1

Other Studies

1 other study(ies) available for rubitecan and Acquired Immune Deficiency Syndrome

Article	Year
9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy. Journal of medical virology, 2001, Volume: 64, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Apoptosis; Camptothecin; Cell Cycle; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Flow Cytometry; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lymphocytes; Reverse Transcriptase Inhibitors; Virus Replication	2001

Article

Year

9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy.

Journal of medical virology, 2001, Volume: 64, Issue:3

Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Apoptosis; Camptothecin; Cell Cycle; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Flow Cytometry; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lymphocytes; Reverse Transcriptase Inhibitors; Virus Replication

2001